Fig. 2: Freedom from progression.

A Freedom from progression for the entire cohort from the date of enrollment by the Kaplan–Meier method (n = 18). B Freedom from progression stratified by a dose of atezolizumab administered (n = 18). Source data are provided as a Source Data file.